The 6 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 250.00, with a high estimate of 315.00 and a low estimate of 206.00. The median estimate represents a +4.41% increase from the last price of 239.43.
The current consensus among 9 polled investment analysts is to Hold stock in West Pharmaceutical Services Inc. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.37
Reporting Date Feb 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.